Skip to main content
Fig. 2 | BMC Pharmacology and Toxicology

Fig. 2

From: Post-marketing safety profile of ganirelix in women: a 20-year pharmacovigilance analysis of global adverse drug event databases (2004–2024)

Fig. 2

Signal detection at the SOC level. (A) A line graph illustrating the annual trend in the number of reports for ganirelix. (B) A distribution plot showing the number of reports categorized by SOC. (C) A forest plot displaying signal strength at the SOC level, represented by ROR values along with their corresponding 95% confidence intervals. Five SOCs that meet the positive signal threshold based on the ROR algorithm are highlighted for emphasis

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us